Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.59 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.58 |
| ▸ | PYGL | P06737 | 1/20 | 0.55 |
| ▸ | PYGM | P11217 | 1/20 | 0.55 |
| ▸ | ACLY | P53396 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.52 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.52 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.52 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.51 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2274007 | 0.94 | GRIK1 (0.57) | GRIK1SLC16A3PYGLPYGMACLY | |
| SCHEMBL2271168 | 0.90 | ACLY (0.67) | GRIK1ACLYMEN1PKMKMT2A | |
| SCHEMBL2275929 | 0.88 | KMT2A (0.62) | GRIK1ACLYMEN1PKMKMT2A | |
| SCHEMBL2274700 | 0.88 | MEN1 (0.55) | GRIK1ACLYMEN1PKMKMT2A | |
| SCHEMBL2272111 | 0.86 | SUCNR1 (0.59) | GRIK1ACLYMEN1PKMKMT2A | |
| SCHEMBL2275745 | 0.85 | NPC1 (0.56) | GRIK1MEN1PKMKMT2AKDM4E | |
| SCHEMBL2273979 | 0.85 | ALDH1A1 (0.58) | GRIK1MEN1PKMKMT2AKDM4E | |
| SCHEMBL2270227 | 0.85 | SLC16A3 (0.58) | SLC16A3ACLYMEN1KMT2AKDM4E | |
| SCHEMBL1308515 | 0.84 | GRIK1 (0.80) | GRIK1SLC16A3PYGLPYGMACLY | |
| SCHEMBL2364731 | 0.84 | SRC (0.58) | GRIK1MEN1KMT2AMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7999132-B2 | Anthranilic acid derivative or salt thereof | TOYAMA CHEMICAL CO., LTD. (JP) | 2011-08-16 | — | — | US | disclosed |
| US-20090240052-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-1820795-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2007-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240052-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | MMP13, MMP26, MMP11 | GRIK1 2029/4885SLC16A3 380/4885PYGL 1834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.